Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 8/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28284649 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL18679878 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL1537692 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL19367023 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL1499895 | 1.00 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL18679884 | 0.93 | NAAA (0.46) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL8384168 | 0.92 | ALDH1A1 (0.50) | NAAAEPHX1TSHRHCAR2ALDH1A1 | |
| SCHEMBL12834794 | 0.86 | PRKCA (0.35) | NAAATSHRNPSR1ALDH1A1 | |
| SCHEMBL862911 | 0.85 | ALDH1A1 (0.47) | NAAAEPHX1TSHRHCAR2ALDH1A1 | |
| SCHEMBL4074831 | 0.85 | NAAA (0.52) | NAAAEPHX1TSHRHCAR2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | LANDEC CORPORATION | 2010-01-07 | — | — | US | disclosed |
| US-20090263346-A1 | Systems and methods for delivery of drugs | LANDEC CORPORATION | 2009-10-22 | — | — | US | disclosed |
| US-20090246155-A1 | Compositions and methods for personal care | LANDEC CORPORATION | 2009-10-01 | — | — | US | disclosed |
| US-7504531-B2 | Processes for preparing difunctional compounds | XEROX CORPORATION (US) | 2009-03-17 | — | — | US | disclosed |
| US-20070255038-A1 | Processes for preparing difunctional compounds | XEROX CORPORATION (US) | 2007-11-01 | — | — | US | disclosed |
| US-20070255071-A1 | PROCESSES FOR PREPARING DIFUNCTIONAL COMPOUNDS | XEROX CORPORATION (US) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263346-A1 | Systems and methods for delivery of drugs | CYCS, CTRC, PPIC | NAAA 2560/4885EPHX1 2864/4885TSHR 3231/4885 |
| US-20090246155-A1 | Compositions and methods for personal care | PPIC, CYCS, CTRC | NAAA 3620/4885EPHX1 3342/4885TSHR 3387/4885 |
| US-20100004124-A1 | Systems and methods for delivery of materials for agriculture and aquaculture | CYCS, PCCA, CRYAA | NAAA 702/4885EPHX1 2792/4885TSHR 4616/4885 |
| US-20070255071-A1 | PROCESSES FOR PREPARING DIFUNCTIONAL COMPOUNDS | ABL2, ABL1, PAICS | NAAA 111/4885EPHX1 1431/4885TSHR 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.